Wednesday, September 11, 2019

November 09, 2019 at 02:33AM Statement on data accuracy issues with recently approved gene therapy

Statement by Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on data accuracy issues with recently approved gene therapy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YQCRGE

No comments:

Post a Comment